COENZILE 10,000µg/20ml, lyophilised, and solvent for solution for injection for cattle, horses, swine, dogs and cats

Land: Cypern

Sprog: græsk

Kilde: Κυπριακή Δημοκρατία, Υπουργείο Γεωργίας, Αγροτικής Ανάπτυξης και Περιβάλλοντος, Κτηνιατρικές Υπηρεσίες

Produktets egenskaber Produktets egenskaber (SPC)
23-02-2023

Aktiv bestanddel:

GRANTED

Tilgængelig fra:

QB03BA04

ATC-kode:

COBAMAMIDE 10.000 μg/ 20ml

INN (International Name):

GRANTED

Lægemiddelform:

FATRO SpA ITALY

Indgivelsesvej:

LYOPHILISATE AND SOLVENT FOR SOLUTION FOR INJECTION

Terapeutisk gruppe:

N. A. CHANCE TRADING CO

Produkt oversigt:

Withdrawal period: CATTLE HORSES PIGS DOGS CATS; Distributor: ANTIANEMIC PREPARATIONS

Produktets egenskaber

                                ΠΑΡΑΡΤΗΜΑ Ι
ΠΕΡΙΛΗΨΗ ΤΩΝ ΧΑΡΑΚΤΗΡΙΣΤΙΚΩΝ ΤΟΥ
ΠΡΟΪΟΝΤΟΣ
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
COENZILE 10,000µg/20ml, lyophilised, and solvent for solution for
injection for
cattle, horses, swine, dogs and cats.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_One bottle of lyophilisate contains:_
ACTIVE SUBSTANCE:
cobamamide.........................................10,000 µg
For a complete list of excipients, see section 6.1.
_One bottle of solvent contains:_
Water for injections.....................................20 ml
3.
PHARMACEUTICAL FORM
Lyophilisate and solvent for solution for injection.
4.
CLINICAL PARTICULARS
4.1.
TARGET SPECIES_ _
Cattle, horses, swine, dogs and cats.
4.2.
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In all states regarding retarded growth, insufficient or difficult
weight gain,
convalescence, hyporexia and anorexia. As stimulant in fatigue with
poor
performance
in
sporting
animals.
As
an
adjuvant
in
anaemia,
hepatopathies and neuropathies. As Vitamin B
12
in Vitamin B
12
avitaminosis and dysvitaminosis with a deficiency of this vitamin.
4.3.
CONTRAINDICATIONS
None.
4.4.
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5.
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
None.
4.6.
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None reported.
1/12
4.7.
USE DURING PREGNANCY, LACTATION OR LAY
COENZILE may be used during pregnancy and lactation.
4.8.
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known.
4.9.
AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
Administer by the intramuscular route
CALVES, FOALS:
5-10ml (2,500 - 5,000µg) per day for 3-6 days.
PIGLETS:
2.5ml (1,250µg) per day, for 3 days.
ADULT CATTLE AND HORSES:10-20ml (5,000 - 10,000µg) per day, for 2-4
days.
ADULT SWINE:
5-10ml (2,500 - 5,000µg) per day, for 2-4 days.
DOGS AND CATS:
2.5-5ml (1,250 - 2,500µg
                                
                                Læs hele dokumentet
                                
                            

Søg underretninger relateret til dette produkt